An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus;Estudio observacional de infusión subcutánea continua de insulina a lo largo de 7 años en el tratamiento de la diabetes mellitus tipo 1

Endocrinologia y Nutricion

Volumn 61, Issue 3, 2014, Pages 141-146

  Papargyri, Panagiota ^a   Ojeda Rodríguez, Sylvie ^a   Corrales Hernández, Juan José ^a   Mories Álvarez, María Teresa ^a   Recio Córdova, José María ^a   Delgado Gómez, Manuel ^a   Sánchez Marcos, Ana Isabel ^a   Iglesias López, Rosa Ana ^a   Herrero Ruiz, Ana ^a   Beaulieu Oriol, Myriam ^a   Miralles García, José Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Continuous subcutaneous insulin infusion; Diabetes mellitus; Hipoglucemia; Hypoglycemia; Infusi n subcut nea continua de insulina; Insulin therapy; Insulinoterapia

Indexed keywords

FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ARTICLE; CONTINUOUS INFUSION; DIABETES EDUCATION; FOOD INTAKE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY DIABETES MELLITUS; RETROSPECTIVE STUDY; ADULT; DIABETES MELLITUS, TYPE 1; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ADULT; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84896725645     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2013.09.003     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group (DCCT).
2. American Diabetes Association: Standards of medical care in diabetes 2012. Diabetes Care 2012, 1(35 Suppl):11-63.
3. DeWitt D.E., Hirsch I.B. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: Scientific review. JAMA 2003, 289:2254-2264.
4. Bulsara M.K., Holman C.D.J., Davis E.A., Jones T.W. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004, 27:2293-2298.
5. Pickup J.C., Keen H., Parsons J., Alberti K. Continuous subcutaneous insulin infusion: An approach to achieving normoglycemia. Br Med J 1978, 1:204-207.
6. Pickup J., Keen H. Continuous subcutaneous insulin infusion at 25 years. Evidence base for expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002, 25:593-598.
7. Pickup J.C. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012, 366:1616-1624.
8. Bruttomesso D., Costa S., Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: Still the best option for insulin therapy. Diabetes Metab Res Rev 2009, 35:99-111.
9. Raile R., Noelle V., Landgraf R., Aschwarz H.P. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab 2002, 15:607-612.
10. Didangelos T., Iliadis F. Insulin pump therapy in adults. Diabetes Res Clin Pract 2011, 93 Suppl 1:109-113.
11. Misso M.L., Egberts K.J., Page M., O'Connor D., Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010, 20:CD005103.
12. Jeitler K., Horvath K., Berghold A., Gratzer T.W., Neeser K., Pieber T.R., et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: Systematic review and meta-analysis. Diabetologia 2008, 51:941-951.
13. Yeh H.C., Brown T.T., Maruthur N., Ranasinghe P., Berger Z., Suh Y.D., et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: A systematic review and meta-analysis. Ann Intern Med 2012, 157:336-347.
14. Fatourechi M.M., Kudva Y.C., Murad M.H., Elamin M.B., Tabini C.C., Montori V.M. Hypoglycemia with intensive insulin therapy: A systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009, 94:729-740.
15. Hirsch I.B., Bode B.W., Garg S., Lane W.S., Sussman A., Hu P., et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005, 28:533-538.
16. Linkeschova R., Raoul M., Bott U., Berger M., Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: An observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002, 19:746-751.
17. Tsui E., Barnie A., Ross S., Parkes R., Zinman B. Intensive insulin therapy with insulin lispro. Diabetes Care 2001, 24:1722-1727.
18. Retnakaran R., Hochman J., DeVries J.H., Hanaire-Broutin H., Heine R.J., Melki V., et al. Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline HbA1c. Diabetes Care 2004, 27:2590-2596.
19. DeVries J.H., Snoek F.J., Kostense P.J., Masurel N., Heine R.J. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002, 25:2074-2080. Dutch Insulin Pump Study Group.